In contrast, the knockdown approach using siRNA allows a quicker on demand evaluation of mechanisms governed by Jnk2, reflecting more closely the human situation, since patient’s liver diseases are the result of changes in gene and/or protein expression. Here, MAPK9 is linked to liver disorder.